{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:27:22Z","timestamp":1779121642805,"version":"3.51.4"},"publisher-location":"Berlin, Heidelberg","reference-count":12,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642373275","type":"print"},{"value":"9783642373282","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/8904_2013_226","type":"book-chapter","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T03:15:31Z","timestamp":1365995731000},"page":"87-92","source":"Crossref","is-referenced-by-count":20,"title":["Substrate Reduction Therapy in Four Patients with Milder CLN1 Mutations and Juvenile-Onset Batten Disease Using Cysteamine Bitartrate"],"prefix":"10.1007","author":[{"given":"M.","family":"Gavin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Logush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Velinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"226_CR02261","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbadis.2006.08.004","volume":"1762","author":"JA Hobert","year":"2006","unstructured":"Hobert JA, Dawson G (2006) Neuronal ceroid lipofuscinoses therapeutic strategies: past, present and future. BBA 1762:945\u2013953","journal-title":"BBA"},{"key":"226_CR02262","unstructured":"Mole SE and Williams RE (2010) Neuronal ceroid lipofuscinoses. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds) Gene reviews. [Internet] Seattle (WA), University of Washington, Seattle"},{"key":"226_CR02263","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1172\/JCI3112","volume":"102","author":"A Das","year":"1998","unstructured":"Das A, Becerra CHR, Yi W, Lu JY, Siakotos AN, Wisniewski KE, Hofmann SL (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the US. J Clin Invest 102:361\u2013370","journal-title":"J Clin Invest"},{"key":"226_CR02264","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2007-973661","volume":"28","author":"SL Hofmann","year":"1997","unstructured":"Hofmann SL, Lee LA, Lu YY, Vekruyse LA (1997) Palmytoyl protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis. Neuropediatrics 28:27\u201330","journal-title":"Neuropediatrics"},{"issue":"4","key":"226_CR02265","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/86554","volume":"7","author":"Z Zhang","year":"2001","unstructured":"Zhang Z, Butler JD, Levin SW, Wisniewski KE, Brooks SS, Mukherjee AB (2001) Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood. Nat Med 7(4):478\u2013484","journal-title":"Nat Med"},{"key":"226_CR02266","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10545-006-0225-z","volume":"29","author":"JY Lu","year":"2006","unstructured":"Lu JY, Hofmann SL (2006) Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: Implications for treatment of infantile neuronal ceroid lipofuscinosis. J Inher Metab Dis 29:119\u2013126","journal-title":"J Inher Metab Dis"},{"key":"226_CR02267","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/929456","volume":"2011","author":"P Goodyer","year":"2011","unstructured":"Goodyer P (2011) The history of cystinosis: lessons for clinical management. Int J Nephrol 2011, 929456. doi:\n                  10.4061\/2011\/929456","journal-title":"Int J Nephrol"},{"key":"226_CR02268","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4172\/2165-7920.1000108","volume":"2","author":"GY Wen","year":"2012","unstructured":"Wen GY, Wisniewski KE, Messing J, Nealy V, Gavin M, Velinov M, Jenkins EC, Brown WT (2012) Cystagon treatment for neuronal ceroid lipofuscinosis: an 8-year case study. J Clinic Case Reports 2:108. doi:\n                  10.4172\/jccr.1000108","journal-title":"J Clinic Case Reports"},{"key":"226_CR02269","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1651-2227.1988.tb10770.x","volume":"77","author":"A Kohlscutter","year":"1988","unstructured":"Kohlscutter A, Laabs R, Albani N (1988) Juvenile neuronal ceroid lipofuscinosis (JNCL): quantitative description of its clinical variability. Acta Paediatr Scand 77:867\u2013872","journal-title":"Acta Paediatr Scand"},{"key":"226_CR022610","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/01913120500406566","volume":"30","author":"GW Anderson","year":"2006","unstructured":"Anderson GW, Smith VV, Brooke I, Malone M, Sebire NJ (2006) Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens. Ultrastruct Pathol 30:373\u2013378","journal-title":"Ultrastruct Pathol"},{"key":"226_CR022611","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJM198704163161602","volume":"316","author":"WA Gahl","year":"1987","unstructured":"Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971\u2013977","journal-title":"N Engl J Med"},{"key":"226_CR022612","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1172\/JCI27607","volume":"116","author":"M Borrell-Pages","year":"2006","unstructured":"Borrell-Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsh E, Hantraye P, Cheetham ME, Neri C, Alberch J, Brouillet E, Saudou F, Humbert S (2006) Cystamine and Cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116:1410\u20131422","journal-title":"J Clin Invest"}],"container-title":["JIMD Reports","JIMD Reports - Volume 11"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2013_226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T05:16:30Z","timestamp":1557638190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2013_226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783642373275","9783642373282"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/8904_2013_226","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}